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An annual survey on cardiac interventions in Europe is
performed by the working group on Coronary Circulation
of the European Society of Cardiology with the help of the
national societies of cardiology. A questionnaire about
cardiac interventions in 1993 was mailed to a representative
of the national societies of 35 members of the European
Society of Cardiology. The data collection of coronary
interventions was delayed by slow backreporting and from
10 of the 35 national members data were missing or grossly
incomplete. They were excluded from the analysis.
Coronary anglography A total of 756 822 coronary
angiograms were reported resulting in an incidence of
1146 ±1024 per 106 inhabitants, ranging from 24
(Romania) to 3499 (Germany). This represents an increase
of 12% compared to 1992. Germany (279 882 cases), France
(157 237), the United Kingdom (77 000), Italy (44 934)
and Spain (37 591) registered 79% of all the coronary
angiograms performed.
Percutaneous transluminal coronary angioplasty A
total of 183 728 percutaneous transluminal coronary
angioplasty cases were reported in 1993, 24% more than in
1992. On average, they accounted for 18 ±7% (range 8
(Romania) to 35% (Sweden)) of the coronary angiograms.
Most of these percutaneous transluminal coronary angio-
plasties (82%) were confined to a single vessel. In 13% only,
percutaneous transluminal coronary angioplasty took place
immediately after the diagnostic study. Adjusted per capita,
Germany ranks first with 873 percutaneous transluminal
coronary angioplasties per 106 inhabitants, followed
by France (737), Holland (725), Belgium (713), and
Switzerland (665). The European mean of percutaneous
transluminal coronary angioplasties per 106 inhabitants was
270 ± 279, representing an increase of 14% compared with
1992. A major in-hospital complication was reported in
3-8% of the patients undergoing percutaneous trans-
luminal coronary angioplasty: 0-6% hospital deaths, 1-5%
emergency coronary artery bypass graftings, and 1-7%
myocardial infarctions.
New devices In 1993 stents were implanted in 6444
patients (3-5% of all percutaneous transluminal coronary
angioplasty patients), equally distributed between bail-out
situations (53%) and elective procedures. The 14 stent
implanting countries showed a mean increase in the
incidence of coronary stenting of 53% compared with 1992.
Other interventional devices were applied in 7045 cases, i.e.
3-8% of all percutaneous transluminal coronary angioplasty
cases. Coronary ultrasound (2194 cases) and coronary
angioscopy (380 cases) were performed infrequently.
Non-coronary Interventions Valvuloplasties were the
most frequently performed non-coronary interventions. Six
European countries performed more than 300 valvulo-
plasties each in 1993. Most of them were mitral valvulo-
plasties in southern countries.
Conclusions Although partial backreporting might bias
conclusions, several findings of this survey are noteworthy
for the participating countries: The number of percu-
taneous transluminal coronary angioplasties is universally
increasing. There is an extremely wide range of coronary
angiography and percutaneous transluminal coronary
angioplasties performed per population. The most common
additional procedure is a stent implantation while other
new devices are only rarely applied. Mitral valvuloplasty is
the most frequently performed non-coronary intervention.
(Eur Heart J 1996; 17: 1318-1328)
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Introduction
Coronary artery disease is a major cause of morbidity
and mortality in Europe. Since the introduction of
coronary bypass surgery in 1969(1'21 and percutaneous
transluminal coronary angioplasty (PTCA) in 1977[3)
ever increasing numbers of patients have been treated
for symptomatic coronary artery disease with these
revascularization modalities. Cardiac surgery and inter-
ventional cardiology techniques are mostly complemen-
tary in modern therapy of coronary, valvular and
congenital heart disease and have gained wide accept-
ance by physicians and patients. However, the utiliza-
tion of these procedures varies widely between European
countries in terms of absolute and relative numbers of
revascularization procedures. Each technique needs con-
tinuous evaluation in respect of immediate and long-
term results including side effects, morbidity, and
mortality. In addition, it is necessary to analyse whether
the differences in coronary artery bypass grafting, per-
cutaneous transluminal coronary angioplasty, and other
interventional techniques among European countries
are caused by differences in perception of the medical
need for revascularization procedures, different socio-
medical-economic situations, and differences in cardio-
vascular morbidity. This information would form the
basis of determining the desired national and European
level of facilities for revascularization procedures,
establish guidelines for their indications, and introduce
quality control measures.
Following a survey focussing on the economic
aspect14', the working group on Coronary Circulation
published its first report of European data on cardiac
interventions performed in 1992[5). Other surveys have
evaluated the number of coronary artery bypass grafts,
coronary angiograms, and percutaneous transluminal
coronary angioplasties of individual countries16"91 and
in Europe1'01, reflecting the need for annual reporting
on coronary interventions. This second survey was
conducted by the study group on Clinical Issues of
the working group on Coronary Circulation and was
intended to collect data on coronary interventions per-
formed in 1993 from all countries belonging to the
European Society of Cardiology.
The principle aim of this survey was to evaluate
the 1993 incidence of various coronary interventions
adjusted per population of the particular country and
to analyse and compare the data of all participating
European countries with the data of 1992. The major
complications were also registered for a first attempt at
quality control.
Methods
In March 1994 a detailed questionnaire was sent to
the presidents or designated delegates of the national
cardiac societies belonging to the European Society of
Cardiology. As for the previous survey, they were asked
to send a copy of the questionnaire to all the centres
performing coronary angiograms and coronary inter-
ventions in their country, to collect all the data from
these centres, to pool their numbers, and to return a
summary of the national data. Attached to the
questionnaire were instructions and examples on how
the questionnaire should be completed.
The following definitions were used:
Coronary angiogram: Diagnostic catheterization with
coronary angiography, irrespective of whether per-
formed in conjunction with other diagnostic studies
or PTCA.
PTCA: Coronary angioplasty procedure (case), irrespec-
tive of instrument used, the number of lesions or vessels
dilated, whether a diagnostic study was carried out
during the same session or whether the patient had an
additional procedure during the same year.
PTCA during diagnostic study. PTCA procedure
performed in a single session immediately following a
diagnostic study producing the indication for PTCA.
Myocardial infarction: According to the most sensitive
screening procedure used locally.
Single vessel PTCA: PTCA of one or more lesions in one
vessel.
Multivessel PTCA: PTCA of more than one vessel in a
single session.
PTCA for acute infarction: PTCA during ongoing
infarction with or without fibrinolysis (direct PTCA).
The initial deadline for backreporting was July
1994. In cases of missing or incomplete data, the
national centres were repeatedly reminded at increas-
ingly shorter intervals. In July 1995 the registry was
closed.
Results
The questionnaire included more than 40 questions. The
high number of questions may explain why backreport-
ing was taking more than one year in some countries. Of
the 35 countries, 10 had to be excluded from the analysis
because of missing or grossly incomplete data. These
were Algeria, Cyprus, the Czech Republic, Egypt,
Iceland, Ireland, Morocco, Portugal, Russia, and
Tunisia. The data of the 25 remaining nations with a
total population of 525 millions are described. They
comprise all those with high interventional activity. The
completed registry was returned to the country
representatives for correction before final compilation.
For comparison, some of the 1992 data'51 are recalled.
General results
A total of 683 888 coronary angiograms and 147 729
PTCAs had been reported for 1992. The figures for 1993
were 756 822 angiograms and 183 728 PTCAs, repre-
senting increases of 11% and 24%, respectively. The vast
majority of PTCAs were carried out electively (87%)
and were confined to a single vessel (82%). PTCA for
acute infarction was attempted in 2606 cases. Major
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Table 1 Major complications
In-hospital death
Need for urgent CABG
Myocardial infarction
of PTC A
1992
0-5%
1 3%
1-5%
1993
0-6%
1 5%
1-7%
CABG = coronary artery bypass grafting
complications were reported with a comparable inci-
dence in 1992 and 1993 (Table 1). The overall use of new
devices including stents, other new therapeutic devices
such as directional atherectomy, rotablator, laser, and
transluminal extraction catheter as well as new diagnos-
tic devices such as coronary ultrasound and coronary
angioscopy was 5-7% and 8-7% of all PTCAs in 1992
and 1993, respectively. Of the new therapeutic devices
used in 1993, stents accounted for 3-5% of PTCAs (1992:
2-2%), rotablators for 2 1 % (1992: 1%), and directional
atherectomy for 1-3% (1992: 08%). The use of lasers and
the transluminal extraction catheter decreased.
Data analysed per nation
Figure 1 shows the European revascularization proce-
dures reported in 1993. The rates of PTC A in Europe
varied from 3 to 873 per 106, and for CABCr1'01 from
2 to 776 per 106. The relative contribution of each
revascularization modality varies widely between
countries. Northern countries favour the use of bypass
surgery, while western countries use more angioplasty.
Since the number of coronary artery bypass graft pro-
cedures were collected by the referring cardiologists,
backreporting in some countries was insufficient. Miss-
ing data were therefore filled in from the data of
Unger110'. For reference, estimated numbers for the
United States are shown in the first column. In all
European countries the number or revascularization
procedures is considerably lower than in the United
States, where probably more than 2500 procedures per
106 inhabitants were performed in 1993.
The total number of coronary angiograms and
PTCAs in 1992 and 1993 are shown in Figures 2 and
3. The four countries Germany, France, Great Britain,
and Italy performed 76% of all coronary angiograms
and 75% of all PTCAs. The highest incidence of
coronary angiograms per population was reported
from Germany followed by France and Austria (Fig.
4). The European mean was 1146 ±1024 coronary
angiograms per 106 inhabitants, which represents an
increase of 12% compared to 1992. Germany also
reported the highest rate of PTCA per population
followed by the Netherlands, France, Belgium,
Switzerland, and Austria (Fig. 5). The European mean
of PTCAs per 106 inhabitants was 270 ± 279, repre-
senting an increase of 14% compared to 1992. The
ratio of PTCAs per coronary angiograms in 1993 was
highest in Sweden (35%) and Belgium (29%) and low-
est in Hungary (8%) (Fig. 6) while the European mean
with 19 ±7% was unchanged compared with 1992. A
comparison of the countries in western and eastern
Europe shows a markedly lower number of coronary
angiograms and PTCAs performed in eastern Europe.
The percentage of multivessel PTCA, defined as PTCA
of at least two major vessels in a single session, ranged
from 8% in Belgium to 45% in Sweden. The European
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Figure 1 Coronary revascularizations, i.e. PTCA and CABG in 1993. Austria (A), Belgium (B),
Bulgaria (BG), Croatia (HR), Denmark (DK), Estonia (EE), Finland (SF), France (F), Germany
(D), Great Britain (GB), Greece (GR), Hungary (H), Italy (I), Latvia (LR), Lithuania (LT),
Luxembourg (L), Netherlands (NL), Norway (N), Poland (PL), Romania (RO), Slovakia (SK),
Slovenia (SLO), Spain (E), Sweden (S), Switzerland (CH), Turkey (TR). 0 = CABG per million;
• = PTCA per million.
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Figure 2 Coronary angiograms (abbreviations as in Fig. 1). H = 1992: 683 888; 0 = 1993:
756 822.
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Figure 3 PTCAs (abbreviations as in Fig. 1). • = 1992: 147 729; 0 = 1993: 183 728.
average was 12 ± 8 % in 1992 and 16 ±14 in 1993.
PTCAs during the diagnostic session (ad hoc PTCAs)
were reported as 50% from Austria followed by
Denmark (49%), Switzerland (39%), Estonia (33%) and
Belgium (22%). The European mean was 12 ±8% in
1992 and 13 ± 16 in 1993. In order to account for the
economic situation and resources of a country the
gross national product (GNP) in ECU was related to
the number of PTCA procedures performed in 1993
for countries with a known GNP. There was a range
from 43 PTCAs per 109 ECUs of GNP performed in
Germany to seven in Denmark (Fig. 7).
New devices
In 1993, a total of 16 063 new devices were used during
PTCA, which is a 90% increase compared to 1992 (Fig.
8). A total of 6444 stents were implanted, 7045 other
therapeutic devices were used such as rotablator, direc-
tional atherectomy, laser, and transluminal extraction
catheter. The number of new diagnostic devices used
during PTCA (intracoronary ultrasound and angio-
scopy) was 2574. The stent was the most frequently used
new therapeutic device (utilized in 3-5% of all PTCAs).
The indications were fairly equally distributed between
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Coronary angiograms per 106 inhabitants (abbreviations as in Fig. 1). •
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Figure 5 PTCAs per 10s inhabitants (abbreviations as in Fig. 1). B = 1992; 0 = 1993.
elective (47%) and bail-out (53%) situations. France,
Italy, Germany, Great Britain, and Spain implanted
70% of all stents (Fig. 9). There were few stent implan-
tations in Eastern Europe. The highest incidence of
coronary stenting per PTCA (Fig. 10) was reported from
Italy, followed by Greece, Spain, and Switzerland with
an average of 4-3 ± 2-5% in the 14 stent implanting
countries. This represents an increase of 53% compared
to the 2-8% in 1992. The use of other new therapeutic
devices per country such as directional atherectomy,
rotablator, laser, and transluminal extraction catheter
are summarized in Fig. 11. They were applied in only 14
countries and the majority of the procedures were
carried out in Germany, France, Spain, Italy, and the
Netherlands. The overall use of other new therapeutic
devices was 3-8% of all PTCAs performed in 1993.
Directional atherectomy (Fig. 12) and the rotablator
(Fig. 13) were used more frequently than in 1992,
particularly in Germany and France. Poland and
Hungary were the only eastern European countries
using several of these sophisticated and expensive
techniques.
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Figure 6 PTCAs per coronary angiograms in 1993 (abbreviations as in Fig. 1).
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Figure 7 FTC As per 109 European currency units
(ECU) of gross national product (GNP) in 1993 (abbre-
viations as in Fig. 1).
Italy. These techniques were rarely applied in other
countries (Fig. 14). Coronary angioscopy examinations
showed a significant increase in France only (Fig. 15).
Non-coronary interventions
Valvuloplasties were the most frequently performed
non-coronary interventions, in particular mitral valvu-
loplasties. Six European countries performed more than
300 valvuloplasties each in 1993. Mitral valvuloplasty
prevailed in southern Europe (Fig. 16). Except for
France, aortic valvuloplasty was rarely applied.
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Figure 8 New devices. • = 1992; 0 = 1993.
New diagnostic devices
New diagnostic devices played a minor role and were
applied in 1-2% and 1-4% of all PTCAs only in 1992
and 1993, respectively. Coronary ultrasound with 2194
applications was the preferred new diagnostic tool in
interventional cardiology, compared with 380 cases of
coronary angioscopy. The number of coronary ultra-
sound examinations continued to grow in Germany and
Discussion
The 1993 survey confirms a large variation of rates of
coronary diagnostic procedures and coronary revascu-
larizations in Europe. In western European countries the
number of coronary angiograms, PTCAs, and newer
interventional techniques is considerably higher than
in eastern European countries. But even among the
western European countries, the rates of coronary
angiograms and PTCAs per capita vary considerably
with Germany, France, Belgium, Holland, Switzerland,
and Austria performing the highest amount of inter-
ventions per capita (Figs 4 and 5). However, the ranking
remains at least partially affected by the accuracy of
backreporting. In general, there is an increase of 11% in
the total number of coronary angiograms performed in
Europe and of 24% in PTCAs compared to 1992, which
is likely to be due to two reasons; first a true increase of
diagnostic and therapeutic procedures and second
improved data collection in 1993. The difference in
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Figure 9 Stent implantations (abbreviations as in Fig. 1). • = 1992: 3211; 0 = 1993: 6444.
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Figure 10 Stent implantations per PTC As (abbreviations as in Fig. 1). H = 1992; 0 = 1993.
the rates of coronary interventions among the western
European counties is also reflected by the incidence
of PTCAs performed per GNP. In countries with a
relatively high GNP, higher rates of coronary interven-
tions seem to be performed per GNP. However, these
calculations do not consider national health budgets and
therefore do not truly reflect issues of national health
policies. Relating PTCAs to the numbers of coronary
angiograms performed per country reveals an interesting
aspect. The rates of PTCAs per coronary angiograms in
the European countries did not change from 1992 to
1993 and remained low with an average of 18%, ranging
from 8% to 35%. If an estimated mean rate of surgical
revascularizations of an additional 18% per coronary
angiogram is considered, on average less than 50%
of coronary angiograms result in a revascularization
procedure.
Looking at new devices in interventional
cardiology, there is an absolute and relative increase in
diagnostic and therapeutic devices, although the overall
rate of new devices used per PTCA remains low, with a
European average of 9% in 1993. The application of
coronary stents dominates (Fig. 8) and continues
to grow significantly (Fig. 9). Again, there is a wide
European variation in the use of stents in absolute and
relative figures (Figs 9 and 10). Even among the five
principal stenting nations of France, Italy, Germany,
Great Britain, and Spain the incidence of stents
implanted per PTCA in 1993 shows a wide range from
2 1% to 91%. In 1993, the 14 nations performing stent
implantations reported a significant increase compared
to 1992 which reached more than 100% in several
countries. According to estimates, the increase was even
more dramatic in 1994. The other new therapeutic
devices such as directional atherectomy, the rotablator,
laser, and transluminal extraction catheter are favoured
by isolated countries only and play a minor role in daily
interventional practice. Most mitral valvuloplasties were
Eur Heart J, Vol. 17, September 1996
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Figure 11 New therapeutic devices (except stents) (abbreviations as in Fig. 1). • = 1992:
3519; 0 = 1993: 7045.
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Figure 12 Directional coronary atherectomy (DCA) (abbreviations as in Fig. 1). B = 1992:
1452; 0 = 1993: 2346.
performed in Spain, France, Turkey, Germany, Italy,
and Poland. Valvuloplasties of other cardiac values were
performed rarely (Fig. 16).
As in 1992, the incompleteness of backreporting
is a clear drawback of the 1993 survey. Only reported
procedures were included. No attempt was made at
extrapolations of non-reported figures. However,
compared with 1992 a larger number of countries,
e.g. Austria, Switzerland, the Netherlands, and Italy
benefited from a tradition of performing national
surveys on cardiac interventions. These countries rely on
an excellent backreporting system, for example through
their national society of interventional cardiology. The
quality of backreporting in other countries is hard to
assess. In general, there seems to be less accurate
backreporting from larger countries, particularly from
those who do not perform national surveys on their
own. An additional problem arose from countries with a
dual system of social and private providers of cardiac
interventions, where a certain rivalry impaired central-
ized data collection. Moreover, some centres were
apparently reluctant to provide data for fear of reactions
from the local or national authorities in case they
scrutinised the data. In subsequent surveys, blinded
handling of the data as per individual centre has to be
guaranteed. The data on surgical back-up and on the
numbers of catheterization laboratories and operators
responsible for the reported figures were not complete
enough for meaningful analysis. The collection system
was improved for future surveys. For non-coronary
Eur Heart J, Vol. 17, September 1996
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Figure 13 Rotablator (abbreviations as in Fig. 1). 0 = 1992: 1232; H = 1993: 3962.
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Figure 14 Coronary ultrasound (abbreviations as in Fig. 1). H = 1992: 1350;
0 = 1993: 2194.
interventions, an additional problem exists in that
paediatric cardiologists performing many of these
procedures are not included in the survey of many
countries. Again, this flaw will be remedied in future
surveys.
According to an American registry, the incidence
of acute major complications is not significantly in-
creased, with new device strategies averaging 40% and
ranging from 2-6% to 8-7% across devices'"1. Adverse
events following PTCA reported in this survey in 1993
were unchanged compared with 1992 but most likely
remain under-reported (Table 1). A regularly updated
data bank run by professionals not directly involved in
the procedures at each institution would overcome this
problem, but is not in the interest of the institution
unless it becomes a universal standard. True quality
control will have to implement this standard regardless
of the high costs involved.
The use of PTCA continues to increase for the
treatment of coronary artery disease in Europe, and
is the preferred revascularization procedure of many
countries when compared with coronary artery bypass
surgery. However, several reasons may account for the
persistent high use of surgery in some countries. Surgical
facilities may be more developed than those for inter-
ventional cardiology, and triple vessel disease may be
prevalent among patients undergoing catheterization
(e.g. Finland). In some countries surgeons are routinely
involved in the decision about therapy (e.g. the
Netherlands) and Switzerland has well developed private
Eur Heart J, Vol. 17, September 1996
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Appendix
List of the principal data coordinators in alphabetical
order of countries:
Austria: Muhlberger V. Belgium: Heyndrickx G.
Bulgaria: Tomov 1. Croatia: Cikes I. Czech Republic:
Vojacek J. Denmark: Aldershvile J. Estonia: Peeba M.
Finland: Olkinuora J. France: Lablanche J. M.
Germany: Reifart N. Greece: Fousas S. Hungary: Keltlai
M. Italy: Specchia G. Latvia: Kalnins U. Lithuania:
Bluzhas J. Luxembourg: Beissel J. Norway: Endresen K.
Poland: Ruzyllo W. Romania: Fotiade B. Slovak Repub-
lic: Fridrich V. Slovenia: Cijan A. Spain: Delcan J. L.
Sweden: Emanuelsson H. Switzerland: Meier B. The
Netherlands: van den Brand M. Turkey: Ozturk M.
United Kingdom: Gray H. H.
Eur Heart J, Vol. 17, September 1996
